Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients

A Double-blind, Double Dummy, Phase IV, Randomized, Multicenter, Parallel Group, Placebo Controlled Trial to Evaluate the Effect of Rosuvastatin on Triglycerides Levels in Mexican Hypertriglyceridemic Patients

The primary purpose of this trial is to determine if the treatment with rosuvastatin 10 and 20mg/day during 8 weeks in hypertriglyceridemic patients will reduce their triglyceride levels.

Inclusion Criteria:

• Patients older than 18 years, both genders, without any previous treatment with statins or other lipid lowering drugs for at least 6 months
• With elevated triglycerides above 200 and below 800mg/dl and willing to follow all study procedures including assisting to clinics, fasting before blood samples and signing a written consent

Exclusion Criteria:

• High levels of low-density lipoprotein cholesterol (LDL-C)
• Unstable cardiovascular condition or awaiting a myocardial revascularization
• Congestive cardiac failure
• Uncontrolled diabetes
• Cancer
• Uncontrolled hypothyroidism
• Familial hypercholesterolemia
• Liver/muscle disease
• Pregnancy
• Other